{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T23:56:04Z","timestamp":1784591764522,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,2,12]],"date-time":"2009-02-12T00:00:00Z","timestamp":1234396800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1007\/s10549-009-0316-2","type":"journal-article","created":{"date-parts":[[2009,2,11]],"date-time":"2009-02-11T17:34:23Z","timestamp":1234373663000},"page":"87-93","source":"Crossref","is-referenced-by-count":20,"title":["CASP8 D302H polymorphism delays the age of onset of breast cancer in BRCA1 and BRCA2 carriers"],"prefix":"10.1007","volume":"119","author":[{"name":"On Behalf of the Group for Assessment of Hereditary Cancer of Valencia Community","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarai","family":"Palanca Suela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Esteban Carde\u00f1osa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Barrag\u00e1n Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"de Juan Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Chirivella Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel","family":"Segura Huerta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Guill\u00e9n Ponce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Mart\u00ednez de Due\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn","family":"Montalar Salcedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Castel S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascual","family":"Bolufer Gilabert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,2,12]]},"reference":[{"key":"316_CR1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/annonc\/mdi098","volume":"16","author":"P Boyley","year":"2005","unstructured":"Boyley P, Ferlay J (2005) Cancer incidence and mortality in Europe 2004. Ann Oncol 16:481\u2013488. doi: 10.1093\/annonc\/mdi098","journal-title":"Ann Oncol"},{"key":"316_CR2","first-page":"861","volume":"55","author":"S Rowell","year":"1994","unstructured":"Rowell S, Newman B, Boyd J et al (1994) Inherited predisposition to breast and ovarian cancer. Am J Hum Genet 55:861\u2013865","journal-title":"Am J Hum Genet"},{"key":"316_CR3","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/gepi.10261","volume":"25","author":"AC Antoniou","year":"2003","unstructured":"Antoniou AC, Easton DF (2003) Polygenic inheritance of breast cancer: implications for design of association studies. Genet Epidemiol 25:190\u2013202. doi: 10.1002\/gepi.10261","journal-title":"Genet Epidemiol"},{"key":"316_CR4","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/378789a0","volume":"378","author":"R Wooster","year":"1995","unstructured":"Wooster R, Bignell G, Lancaster J et al (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789\u2013792. doi: 10.1038\/378789a0","journal-title":"Nature"},{"key":"316_CR5","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PD, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117\u20131130. doi: 10.1086\/375033","journal-title":"Am J Hum Genet"},{"key":"316_CR6","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1073\/pnas.0511301103","volume":"103","author":"S Simchoni","year":"2006","unstructured":"Simchoni S, Friedman E, Kaufman B et al (2006) Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population. Proc Natl Acad Sci USA 103:3770\u20133774. doi: 10.1073\/pnas.0511301103","journal-title":"Proc Natl Acad Sci USA"},{"key":"316_CR7","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/bcr1670","volume":"9","author":"G Chenevix-Trench","year":"2007","unstructured":"Chenevix-Trench G, Milne RL, Antoniou AC et al (2007) An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the consortium of investigators of modifiers of BRCA1 and BRCA2 (CIMBA). Breast Cancer Res 9:104. doi: 10.1186\/bcr1670","journal-title":"Breast Cancer Res"},{"key":"316_CR8","first-page":"843","volume":"8","author":"AM Dunning","year":"1999","unstructured":"Dunning AM, Dunning AM, Healey CS et al (1999) A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 8:843\u2013854","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"316_CR9","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0959-437X(00)00069-1","volume":"10","author":"P Karran","year":"2000","unstructured":"Karran P (2000) DNA double strand break repair in mammalian cells. Curr Opin Genet Dev 10:144\u2013150. doi: 10.1016\/S0959-437X(00)00069-1","journal-title":"Curr Opin Genet Dev"},{"key":"316_CR10","doi-asserted-by":"crossref","first-page":"31941","DOI":"10.1074\/jbc.272.51.31941","volume":"272","author":"AK Wong","year":"1997","unstructured":"Wong AK, Pero R, Ormonde PA et al (1997) RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2. J Biol Chem 272:31941\u201331944. doi: 10.1074\/jbc.272.51.31941","journal-title":"J Biol Chem"},{"key":"316_CR11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0092-8674(00)81847-4","volume":"88","author":"R Scully","year":"1997","unstructured":"Scully R, Chen J, Plug A et al (1997) Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88:265\u2013275. doi: 10.1016\/S0092-8674(00)81847-4","journal-title":"Cell"},{"key":"316_CR12","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1073\/pnas.051624098","volume":"98","author":"E Levy-Lahad","year":"2001","unstructured":"Levy-Lahad E, Lahad A, Eisenberg S et al (2001) A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers. Proc Natl Acad Sci USA 98:3232\u20133236. doi: 10.1073\/pnas.051624098","journal-title":"Proc Natl Acad Sci USA"},{"key":"316_CR13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.18388\/abp.2003_3733","volume":"50","author":"J Blasiak","year":"2003","unstructured":"Blasiak J, Przybylowska K, Czechowska A et al (2003) Analysis of the G\/C polymorphism in the 5\u2032-untranslated region of the RAD51 gene in breast cancer. Acta Biochim Pol 50:249\u2013253","journal-title":"Acta Biochim Pol"},{"key":"316_CR14","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1086\/522611","volume":"81","author":"AC Antoniou","year":"2007","unstructured":"Antoniou AC, Sinilnikova OM, Simard J et al (2007) RAD51 135G\u00a0>\u00a0C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. Am J Hum Genet 81:1186\u20131200. doi: 10.1086\/522611","journal-title":"Am J Hum Genet"},{"key":"316_CR15","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/humu.10081","volume":"19","author":"M Olivier","year":"2002","unstructured":"Olivier M, Eeles R, Hollstein M et al (2002) The IARC TP53 database: new online mutation analysis and recommendations to users. Hum Mutat 19:607\u2013614. doi: 10.1002\/humu.10081","journal-title":"Hum Mutat"},{"key":"316_CR16","doi-asserted-by":"crossref","first-page":"15335","DOI":"10.1073\/pnas.93.26.15335","volume":"93","author":"KK Walker","year":"1996","unstructured":"Walker KK, Levine AJ (1996) Identification of a novel p53 functional domain that is necessary for efficient growth suppression. Proc Natl Acad Sci USA 93:15335\u201315340. doi: 10.1073\/pnas.93.26.15335","journal-title":"Proc Natl Acad Sci USA"},{"key":"316_CR17","first-page":"711","volume":"10","author":"N Buyru","year":"2003","unstructured":"Buyru N, Tigli H, Dalay N (2003) P53 codon 72 polymorphism in breast cancer. Oncol Rep 10:711\u2013714","journal-title":"Oncol Rep"},{"key":"316_CR18","doi-asserted-by":"crossref","first-page":"5098","DOI":"10.1158\/1078-0432.CCR-05-0173","volume":"11","author":"J Tommiska","year":"2005","unstructured":"Tommiska J, Eerola H, Heinonen M et al (2005) Breast cancer patients with p53 Pro72 homozygous genotype have a poorer survival. Clin Cancer Res 11:5098\u20135103. doi: 10.1158\/1078-0432.CCR-05-0173","journal-title":"Clin Cancer Res"},{"key":"316_CR19","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/sj.bjc.6602451","volume":"92","author":"T Ohayon","year":"2005","unstructured":"Ohayon T, Gershoni-Baruch R, Papa MZ et al (2005) The R72P P53 mutation is associated with familial breast cancer in Jewish women. Br J Cancer 92:1144\u20131148. doi: 10.1038\/sj.bjc.6602451","journal-title":"Br J Cancer"},{"key":"316_CR20","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/sj.bjc.6604624","volume":"99","author":"A Osorio","year":"2008","unstructured":"Osorio A, Poll\u00e1n M, Pita G et al (2008) An evaluation of the polymorphisms Ins16\u00a0bp and Arg72Pro in p53 as breast cancer risk modifiers in BRCA1 and BRCA2 mutation carriers. Br J Cancer 99:974\u2013977. doi: 10.1038\/sj.bjc.6604624","journal-title":"Br J Cancer"},{"key":"316_CR21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1471-2407-8-32","volume":"8","author":"S Costa","year":"2008","unstructured":"Costa S, Pinto D, Pereira D et al (2008) Importance of TP53 codon 72 and intron 3 duplication 16\u00a0bp polymorphisms in prediction of susceptibility on breast cancer. BMC Cancer 8:32. doi: 10.1186\/1471-2407-8-32","journal-title":"BMC Cancer"},{"key":"316_CR22","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1124\/mol.65.5.1238","volume":"65","author":"D Siegel","year":"2004","unstructured":"Siegel D, Gustafson DL, Dehn DL et al (2004) NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger. Mol Pharmacol 65:1238\u20131247. doi: 10.1124\/mol.65.5.1238","journal-title":"Mol Pharmacol"},{"key":"316_CR23","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00125817-200203000-00003","volume":"4","author":"DW Nebert","year":"2002","unstructured":"Nebert DW, Roe AL, Vandale SE et al (2002) NAD(P)H:quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease: a HuGE review. Genet Med 4:62\u201370. doi: 10.1097\/00125817-200203000-00003","journal-title":"Genet Med"},{"key":"316_CR24","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1073\/pnas.98.3.1188","volume":"98","author":"G Asher","year":"2001","unstructured":"Asher G, Lotem J, Cohen B et al (2001) Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1. Proc Natl Acad Sci USA 98:1188\u20131193. doi: 10.1073\/pnas.021558898","journal-title":"Proc Natl Acad Sci USA"},{"key":"316_CR25","first-page":"5913","volume":"60","author":"DJ Long","year":"2000","unstructured":"Long DJ, Waikel RL, Wang XJ et al (2000) NAD(P)H:quinone oxidoreductase 1 deficiency increases susceptibility to benzo(a)pyrene-induced mouse skin carcinogenesis. Cancer Res 60:5913\u20135915","journal-title":"Cancer Res"},{"key":"316_CR26","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1182\/blood.V94.2.803","volume":"94","author":"RA Larson","year":"1999","unstructured":"Larson RA, Wang Y, Banerjee M et al (1999) Prevalence of the inactivating 609C\u00a0>\u00a0T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia. Blood 94:803\u2013807","journal-title":"Blood"},{"key":"316_CR27","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.leukres.2006.01.016","volume":"30","author":"P Bolufer","year":"2006","unstructured":"Bolufer P, Barragan E, Collado M et al (2006) Influence of genetic polymorphisms on the risk of developing leukemia and on disease progression. Leuk Res 30:1471\u20131491. doi: 10.1016\/j.leukres.2006.01.016","journal-title":"Leuk Res"},{"key":"316_CR28","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/ng.155","volume":"40","author":"R Fagerholm","year":"2008","unstructured":"Fagerholm R, Hofstetter B, Tommiska J et al (2008) NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer. Nat Genet 40:844\u2013853. doi: 10.1038\/ng.155","journal-title":"Nat Genet"},{"key":"316_CR29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000048245","volume":"62","author":"N Siegelmann-Danieli","year":"2002","unstructured":"Siegelmann-Danieli N, Buetow KH (2002) Significance of genetic variation at the glutathione S-transferase M1 and NAD(P)H:quinone oxidoreductase 1 detoxification genes in breast cancer development. Oncology 62:39\u201345. doi: 10.1159\/000048245","journal-title":"Oncology"},{"key":"316_CR30","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ng1981","volume":"39","author":"A Cox","year":"2007","unstructured":"Cox A, Dunning AM, Garcia-Closas M et al (2007) A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet 39:352\u2013358. doi: 10.1038\/ng1981","journal-title":"Nat Genet"},{"key":"316_CR31","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/35037710","volume":"407","author":"MO Hengartner","year":"2002","unstructured":"Hengartner MO (2002) The biochemistry of apoptosis. Nature 407:770\u2013776. doi: 10.1038\/35037710","journal-title":"Nature"},{"key":"316_CR32","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/35077213","volume":"411","author":"GI Evan","year":"2001","unstructured":"Evan GI, Vousden KH (2001) Proliferation, cell cycle and apoptosis in cancer. Nature 411:342\u2013348. doi: 10.1038\/35077213","journal-title":"Nature"},{"key":"316_CR33","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1093\/jnci\/dji001","volume":"96","author":"G MacPherson","year":"2004","unstructured":"MacPherson G, Healey CS, Teare MD et al (2004) Association of a common variant of the CASP8 gene with reduced risk of breast cancer. J Natl Cancer Inst 96:1866\u20131869","journal-title":"J Natl Cancer Inst"},{"key":"316_CR34","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/jnci\/dji178","volume":"97","author":"B Frank","year":"2005","unstructured":"Frank B, Bermejo JL, Hemminki K et al (2005) Re: association of a common variant of the CASP8 gene with reduced risk of breast cancer. J Natl Cancer Inst 97:1012\u20131013","journal-title":"J Natl Cancer Inst"},{"key":"316_CR35","unstructured":"The Breast Cancer Information Core Database BIC. http:\/\/research.nhgri.nih.gov\/bic\/Member\/index.shtml . Accessed 1 Jan 2009"},{"key":"316_CR36","doi-asserted-by":"crossref","first-page":"10325","DOI":"10.1073\/pnas.90.21.10325","volume":"90","author":"A Ganguly","year":"1993","unstructured":"Ganguly A, Rock MJ, Prockop DJ (1993) Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: evidence for solvent-induced bends in DNA heteroduplexes. Proc Natl Acad Sci USA 90:10325\u201310329. doi: 10.1073\/pnas.90.21.10325","journal-title":"Proc Natl Acad Sci USA"},{"key":"316_CR37","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/ajh.2830380310","volume":"38","author":"AV Todd","year":"1991","unstructured":"Todd AV, Ireland CM, Radloff TJ et al (1991) Analysis of N-ras gene mutations in acute myeloid leukemia by allele specific restriction analysis. Am J Hematol 38:207\u2013213. doi: 10.1002\/ajh.2830380310","journal-title":"Am J Hematol"},{"key":"316_CR38","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/humu.20283","volume":"27","author":"A Osorio","year":"2006","unstructured":"Osorio A, Martinez-Delgado B, Pollan M et al (2006) A haplotype containing the p53 polymorphisms Ins16\u00a0bp and Arg72Pro modifies cancer risk in BRCA2 mutation carriers. Hum Mutat 27:242\u2013248. doi: 10.1002\/humu.20283","journal-title":"Hum Mutat"},{"key":"316_CR39","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1006\/mcpr.2001.0349","volume":"15","author":"V Harth","year":"2001","unstructured":"Harth V, Br\u00fcning T, Abel J et al (2001) Real-time genotyping of cytochrome P4501A1 A4889G and T6235C polymorphisms. Mol Cell Probes 15:93\u201397. doi: 10.1006\/mcpr.2001.0349","journal-title":"Mol Cell Probes"},{"key":"316_CR40","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P (1958) Nonparametric estimations from incomplete observations. J Am Stat Assoc 53:457\u2013481. doi: 10.2307\/2281868","journal-title":"J Am Stat Assoc"},{"key":"316_CR41","first-page":"163","volume":"50","author":"N Mantel","year":"1966","unstructured":"Mantel N (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163\u2013170","journal-title":"Cancer Chemother Rep"},{"key":"316_CR42","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/carcin\/bgi248","volume":"27","author":"B Frank","year":"2006","unstructured":"Frank B, Hemminki K, Wappenschmidt B et al (2006) Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction with the CASP8 D302H variant. Carcinogenesis 27:606\u2013609. doi: 10.1093\/carcin\/bgi248","journal-title":"Carcinogenesis"},{"key":"316_CR43","doi-asserted-by":"crossref","unstructured":"De Vecchi G, Verderio P, Pizzamiglio S, et al. (2008) Evidences for association of the CASP8 \u2212652 6N del promoter polymorphism with age at diagnosis in familial breast cancer cases. Breast Cancer Res Treat (in press)","DOI":"10.1007\/s10549-008-9963-y"},{"key":"316_CR44","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/ng2030","volume":"39","author":"T Sun","year":"2007","unstructured":"Sun T, Gao Y, Tan W et al (2007) A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers. Nat Genet 39:605\u2013613. doi: 10.1038\/ng2030","journal-title":"Nat Genet"},{"key":"316_CR45","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/ijc.23448","volume":"123","author":"SJ Ramus","year":"2008","unstructured":"Ramus SJ, Vierkant RA, Johnatty SE et al (2008) Consortium analysis of 7 candidate SNPs for ovarian cancer. Int J Cancer 123:380\u2013388. doi: 10.1002\/ijc.23448","journal-title":"Int J Cancer"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-009-0316-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-009-0316-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-009-0316-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T16:51:35Z","timestamp":1589561495000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-009-0316-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,12]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["316"],"URL":"https:\/\/doi.org\/10.1007\/s10549-009-0316-2","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,12]]}}}